Literature DB >> 11418156

Airborne outbreak of nosocomial Scedosporium prolificans infection.

A Guerrero, P Torres, M T Duran, B Ruiz-Díez, M Rosales, J L Rodriguez-Tudela.   

Abstract

We describe six inpatients with acute non-lymphocytic leukaemia who developed invasive infection with Scedosporium prolificans resistant to amphotericin B, flucytosine, ketoconazole, fluconazole, and itraconazole. All six patients died. Phenotypic and genotypic assessment of samples from clinical material and ambient air from the isolation rooms where the patients were being treated showed that the epidemic was caused by a single strain. After implementation of aerial control measures, there were no further infections with this organism. We conclude that fatal multidrug-resistant S prolificans epidemics can be aerially transmitted and can be prevented with implementation of appropriate infection-control measures.

Entities:  

Mesh:

Year:  2001        PMID: 11418156     DOI: 10.1016/S0140-6736(00)04423-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

Authors:  B P Howden; M A Slavin; A P Schwarer; A M Mijch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-14       Impact factor: 3.267

2.  Treatment options in emerging mold infections.

Authors:  Patricia Muñoz; Jesús Guinea; Emilio Bouza
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

3.  Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy.

Authors:  Yotaro Ochi; Nobuhiro Hiramoto; Hiroshi Takegawa; Noboru Yonetani; Asako Doi; Chihiro Ichikawa; Yukihiro Imai; Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

Review 4.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 5.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.

Authors:  Lynn Purkins; Nolan Wood; Katie Greenhalgh; Michael J Allen; Stuart D Oliver
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

7.  Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates.

Authors:  Yongqin Wu; Nina Grossman; Marissa Totten; Warda Memon; Anna Fitzgerald; Chunmei Ying; Sean X Zhang
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 8.  Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?

Authors:  Laura Elena Carreto-Binaghi; Lisandra Serra Damasceno; Nayla de Souza Pitangui; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Rosely Maria Zancopé-Oliveira; Maria Lucia Taylor
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

9.  Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.

Authors:  Laurence Delhaes; Azian Harun; Sharon C A Chen; Quoc Nguyen; Monica Slavin; Christopher H Heath; Krystyna Maszewska; Catriona Halliday; Vincent Robert; Tania C Sorrell; Wieland Meyer
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Infection with Scedosporium apiospermum and S. prolificans, Australia.

Authors:  Louise Cooley; Denis Spelman; Karin Thursky; Monica Slavin
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.